CNP
73
2
LH
38
3
EMC
15
3
JNJ
44
3
TMO
40
2
CAT
44
2
IRM
46
5
MAS
64
13
LUV
45
-7
VIX
55
-2
BXP
44
3
MAC
55
4
RF
67
6
URI
45
2
NWL
31
-4
DOV
59
2
VTR
58
-2
AAL
44
29
FDX
51
14
USB
51
5
CNP
73
2
LH
38
3
EMC
15
3
JNJ
44
3
TMO
40
2
CAT
44
2
IRM
46
5
MAS
64
13
LUV
45
-7
VIX
55
-2
BXP
44
3
MAC
55
4
RF
67
6
URI
45
2
NWL
31
-4
DOV
59
2
VTR
58
-2
AAL
44
29
FDX
51
14
USB
51
5
Financhill
Back

Plus Therapeutics Stock Price Chart

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18

PSTV
Plus Therapeutics

Last Price:
$0.77
Seasonality Move:
-5.69%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.

Plus Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.2 Sell
20-day SMA: 1.06 Sell
50-day SMA: 1.09 Sell
200-day SMA: 1.35 Sell
8-day EMA: 1.08 Sell
20-day EMA: 1.07 Sell
50-day EMA: 1.09 Sell
200-day EMA: 1.38 Sell

Plus Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 46.14 Sell
Chaikin Money Flow: -757906 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 1.36) Sell
Bollinger Bands (100): (0.93 - 1.39) Sell

Plus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Plus Therapeutics Stock

Is Plus Therapeutics Stock a Buy?

  • Plus Therapeutics share price is 0.89 while PSTV 8-day simple moving average is 1.20, which is a Sell signal.
  • The stock price of PSTV is 0.89 while Plus Therapeutics 20-day SMA is 1.06, which makes it a Sell.
  • Plus Therapeutics 50-day simple moving average is 1.09 while PSTV share price is 0.89, making it a Sell technically.
  • PSTV stock price is 0.89 and Plus Therapeutics 200-day simple moving average is 1.35, creating a Sell signal.

PSTV Technical Analysis vs Fundamental Analysis

Sell
18
Plus Therapeutics (PSTV) is a Sell

Is Plus Therapeutics a Buy or a Sell?

  • Plus Therapeutics stock is rated a Sell
    The current Plus Therapeutics [PSTV] share price is $0.89. The Score for PSTV is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.

Plus Therapeutics Stock Info

Market Cap:
5.2M
Price in USD:
0.89
Share Volume:
1.8M

Plus Therapeutics 52-Week Range

52-Week High:
2.67
52-Week Low:
0.24
Sell
18
Plus Therapeutics (PSTV) is a Sell

Plus Therapeutics Share Price Forecast

Is Plus Therapeutics Stock a Buy?

  • Plus Therapeutics share price is 0.89 while PSTV 8-day exponential moving average is 1.08, which is a Sell signal.
  • The stock price of PSTV is 0.89 while Plus Therapeutics 20-day EMA is 1.07, which makes it a Sell.
  • Plus Therapeutics 50-day exponential moving average is 1.09 while PSTV share price is 0.89, making it a Sell technically.
  • PSTV stock price is 0.89 and Plus Therapeutics 200-day simple moving average is 1.38, creating a Sell signal.

Fundamental Analysis of Plus Therapeutics

Is Plus Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.12 per share, and an increase next year of $0.11 per share.

Technical Analysis of Plus Therapeutics

Should I short Plus Therapeutics stock?

* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.